Kumar Brothers Pharma Private Limited, a active private limited company, was established on 02 March 2005 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH2005PTC151712. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 25 professional, Its leadership includes Bhavesh Jain Surendra (Director), Kunal Kumarpal Jain (Director), Kumarpal Bhabutmal Jain (Director). Past directors included Kokila Surendra Jain, Nikita Jain Kirtesh, Kunal Kumarpal Jain. It holds ₹3.21 Cr open charges and ₹3.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A1,Unit No 204,2Nd Floor,Centre Point,Condominium, 243A,N.M.Joshimarg,Bawlamasjid Delisle,L, Ower Parel, Mumbai, Maharashtra, 400013.
U24230MH2005PTC151712
151712
02 March 2005
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Kumar Brothers Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhavesh Jain Surendra | Director | 02 Mar 2005 | Current |
| Kunal Kumarpal Jain | Director | 03 Dec 2018 | Current |
| Kumarpal Bhabutmal Jain | Director | 03 Dec 2018 | Current |
| Surendra Bhabutmal Jain | Managing Director | 02 Mar 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2013 | Past |
| Pramod Abcsdd | Director | 30 Mar 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 11 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kumar Brothers Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.45% increase. The company also saw a slight decrease in profitability, with a 6.14% decrease in profit. The company's net worth moved up by a moderate rise of 6.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Kumar Brothers Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹32,100,000.00
₹30,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Apr 2015 | Hdfc Bank Limited | ₹1.50 Cr | Open |
| 05 Sep 2006 | Hdfc Bank Limited | ₹1.25 Cr | Open |
| 25 Oct 2005 | The United Western Bank Ltd. | ₹3.60 M | Open |
| 26 Mar 1976 | Central Bank Of India | ₹1.00 M | Open |
| 21 Aug 2007 | Union Bank Of India | ₹3.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Kumar Brothers Pharma has a workforce of 25 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kumar Brothers Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kumar Brothers Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kumar Brothers Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Kumar Brothers Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Kunal Kumarpal Jain was appointed as a Director was appointed as a Director on 03 Dec 2018 & has been associated with this company since 7 years 1 month . was completed.
Kumarpal Bhabutmal Jain was appointed as a Director was appointed as a Director on 03 Dec 2018 & has been associated with this company since 7 years 1 month . was recorded as a recent event.
Progress on A charge registered on 21 Aug 2007 via Charge ID 10066713 with Union Bank Of India was fully satisfied on 20 Apr 2015. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 15.00 M with Charge ID 10567144 was registered on 09 Apr 2015. was completed.
The CIN of Kumar Brothers Pharma Private Limited is U24230MH2005PTC151712.
Kumar Brothers Pharma Private Limited is headquartered at A1,Unit No 204,2Nd Floor,Centre Point,Condominium, 243A,N.M.Joshimarg,Bawlamasjid Delisle,L, Ower Parel, Mumbai, Maharashtra, 400013.
Kumar Brothers Pharma Private Limited was incorporated on 02 March 2005.
The current directors of Kumar Brothers Pharma Private Limited are
The primary industry of Kumar Brothers Pharma Private Limited is Trade.
Kumar Brothers Pharma Private Limited is unlisted.
The authorized capital of Kumar Brothers Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Kumar Brothers Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX